23 results on '"SWAMINATHAN, APARNA"'
Search Results
2. Co-evolution of SARS-CoV-2 variants and host immune response trajectories underlie COVID-19 pandemic to epidemic transition
3. Lung transplantation during acute exacerbations of interstitial lung disease and post-transplant survival
4. Evaluation of Frailty Measures and Short-term Outcomes After Lung Transplantation
5. SARS-CoV-2 VOCs, Mutational diversity and clinical outcome: Are they modulating drug efficacy by altered binding strength?
6. Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO Registry
7. Lung Transplant Outcomes in Patients With Pulmonary Fibrosis With Telomere-Related Gene Variants
8. The impact of a measurement and feedback intervention on blood pressure control in ambulatory cardiology practice
9. 11 - Interactions shaping the interactome: genome surveillance inclusive of host–pathogen
10. Chapter 9 - A Tour-d’Horizon of microbiota therapeutics for metabolic disorders
11. CHARACTERISTICS AND PREVALENCE OF ENVIRONMENTAL AND OCCUPATIONAL EXPOSURES AMONG PATIENTS WITH INTERSTITIAL LUNG DISEASES
12. EVALUATION OF CONTENT VALIDITY OF A NEW EXPOSURE ASSESSMENT QUESTIONNAIRE IN PATIENTS WITH FIBROSING INTERSTITIAL LUNG DISEASES
13. ASSOCIATION OF HRCT PATTERNS AND TRANSPLANT-FREE SURVIVAL IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES (ILDS) IN THE ILD-PRO REGISTRY
14. CHARACTERISTICS OF PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES (ILDS) IN THE ILD-PRO REGISTRY
15. CHARACTERISTICS OF PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES IN THE ILD-PRO REGISTRY BY TIME BETWEEN DIAGNOSIS AND ENROLLMENT
16. List of contributors
17. Contributors
18. PATIENT PREFERENCES FOR TREATMENT OF CHRONIC COUGH: PRELIMINARY FINDINGS FROM A DISCRETE CHOICE EXPERIMENT
19. CHARACTERISTICS OF PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE (ILD): DATA FROM THE ILD-PRO REGISTRY
20. OUTCOMES OF PATIENTS ACROSS THE SPECTRUM OF PULMONARY HYPERTENSION GROUPS PRESCRIBED INHALED TREPROSTINIL
21. DISEASE SEVERITY AND QUALITY OF LIFE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): AN ANALYSIS OF THE IPF-PRO REGISTRY
22. HEALTH-RELATED QUALITY OF LIFE MEASURES IN IDIOPATHIC PULMONARY FIBROSIS: DATA FROM THE IPF-PRO REGISTRY
23. That Was Then, This Is Now: A Fresh Look at Idiopathic Pulmonary Fibrosis Biomarkers in the Antifibrotic Era
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.